ConductScience.org, home

Gene · 5921

NIH grants2,330

NIH grants whose papers are about the gene, through NIH's grant-paper links.

101 to 120 of 2,330

Download this page as JSON
GrantTitleRASA1 papersNewest fiscal year
ZIABC010329Regulation of Ras-Dependent Signal Transduction Pathways22025
ZIABC011091Cancer Genomics Technology Development22025
ZIABC011869Advancing RAS and RASopathy Therapies22025
ZIAHG200328Rare & Mosaic Disorders Molecular Research22025
ZIBHG000196Inter- and Intra-Species Comparative Sequencing22025
ZIDBC011517Pediatric Oncology Branch Behavioral Science Core22025
F30CA260977T cell expressed miR-155 promotes antitumor immunity and immune checkpoint blockade responses in colon cancer through repression of Ship112025
I01BX002301Combining Immune Therapy with Targeted Therapies to Improve Melanoma Survival12025
I01BX003335Mechanisms underlying dampened ischemic tolerance in type 2 diabetes12025
K08CA256489Co-targeting BET Bromodomain Proteins and Aberrant Signaling in AML.12025
K08CA280388Repurposing RET Inhibitors for Endocrine Resistant Breast Cancer12025
K08DK125768Delineation of pathogenic mechanisms of NOS1AP and TRIM8 mutations in monogenic SRNS/FSGS.12025
K12EY016335Harvard-Vision Clinical Scientist Development Program12025
K12GM000678Institutional Research and Academic Career Development Awards (IRACDA) - UNC Postdoctoral Fellowship Program12025
K12HD001262Women's Reproductive Health Research12025
K12HD052896Child Health Research Career Development Award (CHRCDA) Program (K12)12025
KL2TR001862Institutional Career Development Core12025
KL2TR002385I. Institutional Career Development Core12025
P01AG029531The Aging Pituitary/Gonadal Axis12025
P01AG036694Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/5921/grants?page=6